Anand Shah is currently an advisor at Big Health. Anand has previously held positions at Hero, Adagio Therapeutics, M2GEN, Morgan Stanley, and the Centers for Medicare & Medicaid Services. Anand has also served as a board director for the Leonard Davis Institute of Health Economics and as deputy commissioner for medical and scientific affairs at the FDA. Shah is a radiation oncologist by training and has been with the National Institutes of Health since 2016.
Anand Shah completed their undergraduate degree at Duke University in Economics. Anand then attended medical school at the University of Pennsylvania and earned their M.D. Afterwards, they pursued a Master of Public Health degree at Harvard University in the field of Health Care Management and Policy.